EMEA-002051-PIP02-16

Key facts

Invented name
Active substance
Allopregnanolone
Therapeutic area
Psychiatry
Decision number
P/0357/2017
PIP number
EMEA-002051-PIP02-16
Pharmaceutical form(s)
Intravenous use
Condition(s) / indication(s)
Treatment of postpartum depression
Route(s) of administration
Solution for infusion
Contact for public enquiries
Sage Therapeutics Inc
Tel. +1 6172998380
E-mail: contact@sagerx.com
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating